Influenza
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age >= 18 years, gender unlimited; (2) The clinical diagnosis is influenza, and within 3 days of onset; a. Fever >= 38 ? (axillary) during pre dose examination or within 4 hours after taking antipyretics; b. At least one of the following systemic and respiratory symptoms related to influenza (excluding chronic symptoms that existed within 30 days before the onset of influenza) is moderate or above in severity: Systemic symptoms (headache, fever or chills, muscle soreness or fatigue) Respiratory symptoms (cough, sore throat or nasal congestion) (3) The patient agreed to participate in this trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Use of anti influenza drugs; (2) Patients with severe influenza virus infection requiring hospitalization; (3) Patients with serious basic diseases accompanied by important organs such as heart, lung, liver and kidney; (4) Patients with severe systemic infection and malignant tumor; (5) High sensitivity constitution, including allergic bronchial asthma; (6) Patients with mental disorders; (7) Pregnant, lactating or preparing for pregnancy; (8) Subjects considered by the investigator as unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time to alleviation of influenza symptoms;Adverse event; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nucleic acid conversion rate;Co-medication rate; | — |
Countries
China
Contacts
The 986th Air Force hospital